Profil
Kevin Paul Starr est un homme d'affaires qui a fondé Third Rock Ventures LLC et Decibel Therapeutics, Inc. et qui a été à la tête de 5 entreprises différentes. Il est actuellement président de SAGE Therapeutics, Inc. et associé de Third Rock Ventures LLC. Au cours de sa carrière, M. Starr a occupé les postes de président-directeur général de Decibel Therapeutics, Inc, président d'Agios Pharmaceuticals, Inc, président d'Afferent Pharmaceuticals, Inc, directeur d'Ember Therapeutics, Inc, directeur de l'exploitation et des finances de Millennium Pharmaceuticals, Inc, directeur de Digital Equipment Corp et contrôleur de Biogen MA, Inc. M. Starr a obtenu un diplôme de premier cycle au Colby College et un diplôme d'études supérieures au Boston College.
Anciens postes connus de Kevin Starr
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Président | 05/01/2024 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Fondateur | 02/01/2021 |
| MYOKARDIA, INC. | Directeur/Membre du Conseil | 06/03/2018 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2018 |
| DECIBEL THERAPEUTICS, INC. | Directeur Général | 13/07/2016 |
Formation de Kevin Starr
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Digital Equipment Corp.
Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Manufactures lightweight photovoltaic cells | Electronic Technology |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colby College
Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Health Technology |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
















